Most Recent Byetta Side Effects Information As of October 2025, the most common Byetta side effects reported to the FDA were hyperglycemia, weight loss, low blood sugar and gastrointestinal upset (nausea, vomiting and diarrhea)
All three amylin products appear to have the potential to challenge tirzepatide on an efficacy/tolerability basis, so it will be interesting to see how Novo Nordisk and Eli Lilly position these products alongside their current GLP-1 offerings
Semaglutide is administered by a subcutaneous injection, commonly dosed once weekly
It does not practice medicine and does not directly provide medical care
The gasdermin D-cleaving protease exclusively induced lytic death, whereas the procaspase-1-cleaving variant initiated both lytic and apoptotic cell death
The main restraint is regulatory scrutiny of promotion, especially claims about compounded GLP-1 products and product equivalence